Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer Patients
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This phase III study is designed to examine if low-risk (lymph node negative), stage I a2-II
b cervical cancer patients treated by paclitaxel/cisplatin chemoradiation have greater
toxicities but similar survival rate as those treated by radiotherapy alone.